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1,4‑Naphthoquinones for Topical Application with Antioxidant 
Potential
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Abstract
Discovering new antioxidant agents and optimizing their processing is a necessity to treat skin diseases. The assessment of
quality and antioxidant activity of topical formulations based on 5,8-dihydroxy-1,4-naphthoquinone (M1) and 2,3-dichloro-
5,8-dihydroxy-1,4-naphthoquinone (M2) was carried out for the first time for this purpose. Stability studies including evalu-
ation of pH, viscosity, microscopic observation, and microbiological quality were determined. M1 and M2 were examined
for their antioxidant capacities after their incorporation into bigels. Obtained data suggested that BG-M1 and BG-M2 have a 
good quality, a natural pH of the skin (4.5–6.0), and no sign of microbial development. Sensory analysis was also performed, 
and no negative assessment of unpleasant bigel properties was found. M1 and M2 have shown antioxidant activity toward 
DPPH radical (data are expressed as IC50), 19 × 10−3 mg/mL for M1 and 35 × 10−3 mg/mL for M2, respectively. After their 
formulations, they have maintained this ability, for BG-M1 = 3.0 and BG-M2 = 1.1 mg/mL. Also, they demonstrated inter-
esting ABTS scavenging with 1.5 × 10−3 and 2.5 × 10−3 mg/mL for M1 and M2, respectively. They kept this potential after 
formulation, since, BG-M1 = 1.7 mg/mL and BG-M2 = 4.9 mg/mL. Likewise, pure molecules revealed notable β-carotene 
bleaching inhibition (0.3 and 0.1 mg/mL for M1 and M2, respectively), which was maintained after their formulation into
bigels (2.9 and 10.3 mg/mL for BG-M1 and BG-M2, respectively). These developed bigels maintaining the antioxidant
potential of M1 and M2 could be used as the provision of a barrier to protect skin.
Keywords 5,8-Dihydroxy-1,4-naphthoquinone · 2,3-Dichloro-5,8-dihydroxy-1,4-naphthoquinone · Physicochemical 
characterization · Sensory analysis · Antioxidant · Bigel formulation
1 Introduction
Oxidative stress appears when the balance between pro-
oxidant and antioxidant species is broken in favor of the 
pro-oxidant state. Probably, the rupture of this balance could 
be due to the promotion of reactive oxygen species (ROS), 
oxygenated free radicals, or both [1]. Although some ROS
physiologically act as cellular messengers in redox signal-
ing, several studies indicate that they are involved in the
development of cardiovascular diseases [2]. It has been also 
proved their implication in many pathologies such as athero-
sclerosis [3], diabetes type 2, inflammation [4, 5], and cancer
[6, 7]. Furthermore, ROS may be damaging and may play a
causative role in aging and several diseases associated with 
it, which often manifest adversely in the skin [8–11]. Folk
therapy has gained a big interest, and several plant prepara-
tions are used for various disorders including those of the 
skin [12, 13]. According to the World Health Organization 
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(WHO), in the country side of developing countries, 80% of 
people use traditional therapies. The difficulty in extracting 
active ingredient from a plant in on the one hand, and its 
low productivity on the other hand, promotes resorting to 
the use of pure compounds. 1,4-Naphthoquinones (1,4-NQ) 
are secondary metabolites present in nature and constitute 
a large family of ubiquitous and varied substances, from 
simple molecules to complex structures. A big number of 
quinones has been characterized in plants, and they might 
be found naturally in dark walnut tree (Juglans nigra), in 
the leaves of Lawsonia inermis (Henna) [14, 15], and others 
have been synthetized. Inside each of its classes, variations 
around the basic chemical skeleton essentially concern the 
degree of hydroxylation, glycosylation, methylation, or oxi-
dation, and the possible connections to other molecules. 1,4-
NQ are valuable molecules possessing scavenging properties 
toward radical oxygen species [16].
This potential makes quinones interesting for the treat-
ment of various diseases like cancer [17], inflammation [18], 
or antiaging purposes [9]. Unfortunately, these compounds 
are characterized by their low stability, making them very 
sensitive to light and heat. 1,4-NQ present also a poor bio-
disponibility mainly due to their low water solubility.
The objective of the current investigation is to for-
mulate for the first time bigel-based alginate with 
active 5,8-dihydroxy-1,4-naphthoquinone (M1) and 
2,3-dichloro-5,8-dihydroxy-1,4-naphthoquinone (M2) for topi-
cal application. Further, their characterization and antioxidant 
evaluation, in comparison with free quinones, will be performed.
2  Materials and Methods
2.1  Materials
5,8-Dihydroxy-1,4-naphthoquinone (Fig. 1a), 2,3-dichloro-
5,8-dihydroxy-1,4-naphthoquinone (Fig. 1b), 1,1-diphenyl-
2-picrylhydrazyl (DPPH), 2,2-azinobis-3-ethylbenzothiazo-
line-6-sulfonate (ABTS), potassium persulfate,  NaH2PO4,
 Na2HPO4,  K2S2O8, acid alginic, span 65, beta carotene, lin-
oleic acid, Tween 40, chloroform, distilled water, dimethyl-
sulfoxide (DMSO),  K3Fe (CN)6, trichloroacetic acid, and
 FeCl3 were purchased from Sigma-Aldrich, France, and the
stock solution of M1 and M2 was prepared in DMSO and
stored at 4 ± 0 °C in the dark. Sweet almond oil was pur-
chased from (Amazon, Toulouse, France). All chemicals
used were of the highest grade commercially available.
2.2  Methods
2.2.1  Development of Bigel Base and Bigel with Active 
Molecules
The composition of blank bigel and the bigel with M1 and 
M2 is shown in Table 1. Hydrogel and organogel (50/50) 
(w/w) were prepared separately and stirred with an ultra-
turrax (6000 rpm) at 60 ± 0 °C. The organogel was prepared 
with the sweet almond oil as apolar solvent, and span 65 as 
organogelator. The complex was prepared at 60 ± 0 °C and 
then cooled over night at 4 ± 0 °C. To make the hydrogel, 
alginate was chosen at concentration of 3% (w/v) and mixed 
with water, using a mechanical homogenizer (300 rpm) for 
60 min. The active molecules were then added continuously 
Fig. 1  Chemical structures of a: 5, 8-dihydroxy-1,4-naphthoquinone 
(M1), and b 2,3-dichloro-5, 8-dihydroxy-1,4-naphthoquinone (M2)
Table 1  Composition and 
proportion of different samples: 
blank bigel, bigel with M1 and 
M2, and  cetavlon®
a AI active ingredient
Samples Compounds Formulation (w/w) Formulation (%)
Bases (for 10 g) Bigel with  AIa
Hydrogel Alginate 0.3 50
Water 9.7
Organogel Span 65 2.0 50
Sweet almond oil 8.0
5,8-Dihydroxy-1,4-naphthoquinone (M1) 1.0
2,3-Dichloro-5,8-dihydroxy-1,4-naphtho-
quinone (M2)
1.0
Cetavlon® Alcohol 3.3
Paraffin 6.6
Cetrimide 0.05 0.5
stirred to the organogel before adding the aqueous phase. 
The amount of M1 and M2 in the bigels were kept constant 
at 1% (w/w). Blank bigel was prepared in the same man-
ner without adding active compounds. Prepared bigels were 
stored at 25 ± 2 °C in well-closed glass containers protected 
from light. The developed bigels were evaluated for their 
organoleptic properties (homogeneity, texture, and fresh-
ness) and pH [19].
2.2.2  Physicochemical Characterization
2.2.2.1 pH Measurement The pH was determined at 
27 ± 0 °C by measuring that of a tenth dilution of each for-
mulation in distilled water using the pH meter (Bante Instru-
ments 950). Under the same conditions, the pH of each 
excipient was measured [19]. All the measurements were 
performed in triplicate.
2.2.2.2 Rheological Study The flow properties of the bigels 
were studied using a rheometer (Thermo Scientific HAAKE 
RS75 Rheo Stress) at 25 ± 2 °C to determine the character 
of the formulation obtained [20, 21]. Three recordings were 
taken per sample.
2.2.2.3 Differential Centrifugation The resistance of the 
formulated bigels to centrifugation was tested in a 2-mL 
graduated cylinder, once at 4000  rpm for 10  min and at 
25 ± 2 °C and then again at 5000 rpm for 10 min as well, 
using a centrifuge (Eppendorf AG 22331 Hamburg) as 
described by Cockton and Wynn [22].
2.2.2.4 Microscopic Observations The microstructure of 
formulated bigels, in terms of particle size distribution, 
number and shape were studied via 3D digital microscopic 
analysis [21]. Samples were prepared by spreading a very 
thin layer of the bigel on the specimen slide and pressing it 
well with a cover slip. Micrographs were obtained using the 
microscope model VHX 3D (kayence VHX), equipped with 
objective 40 ×  and taken on undiluted samples.
2.2.2.5 Formulation Stability (Safety Assay) Bigels with 
1% of quinones were evaluated immediately after prepara-
tion and after lapse of almost 12 months of storage at the 
temperature of 25 ± 2 °C. Microbiological examination was 
carried out in conformity with requirements of European 
Pharmacopoeia for non-sterile products [23–25].
2.2.2.6 Sensory Analysis The sensory analysis (hedonic 
test type) of the prepared formulations was carried out with 
a panel of untrained subjects (60 people) under well-defined 
conditions to ensure an objective and a neutral evaluation as 
possible of the prototype of formulated bigels [26]. It refers 
to the qualitative properties of the formulation, perceived 
by the customer and which must be adapted to the intended 
application. Thus, evaluated parameters were the following: 
homogeneous appearance, non-oily, ease of spreading, short 
penetration time, and freshness.
2.2.3  Antioxidant Activity
2.2.3.1 DPPH Test Antioxidant-scavenging activity was 
studied using DPPH assay as described by [27] with some 
modifications. 20  µL of various dilutions of each sample 
was mixed with a 0.2 mM methanolic DPPH solution. After 
30 min of incubation at 25 ± 2 °C, the absorbance at 524 nm 
was recorded as A(sample). For the A(blank), we applied the 
same experimentation for a solution devoid of the test mate-
rial, and then we recorded the absorbance. Then, for each 
solution, we calculated the free-radical-scavenging activity 
as percent inhibition as the following equation:
The  IC50 is the concentration required for the test for-
mulation to cause a 50% decrease in DPPH concentration. 
Ascorbic acid was used as reference. All the measurements 
were performed in triplicate.
2.2.3.2 ABTS Assay BG-M1, BG-M2, standard ointment, 
and blank bigel were subjected to evaluation of their ability 
to scavenge free radicals by using ABTS radical assay as 
described by [27] with some modifications. A solution of 
ABTS (7 mM) was mixed with 2.5 mM of  K2S2O8, followed 
by storage for 16 h in the dark at 25 ± 2 °C. The mixture was 
then diluted with water, and the absorbance was determined 
at 734 nm. 20 µL of ABTS diluted was added to each sam-
ple. The capacity of free radical scavenging was expressed 
by  IC50, which indicates the required concentration to scav-
enge 50% of ABTS radicals. The same equation described 
previously for the DPPH assay was used to calculate this 
capacity. Ascorbic acid was used as reference. All measure-
ments were performed in triplicate.
2.2.3.3 Reducing Power Assay The ability of the tested sam-
ples to reduce  Fe3+ was assessed by the method of Oyaizu 
[28] with slight modifications. 20 µL of samples was mixed
with 0.2 M phosphate buffer (pH 6.6) and 1%  K3Fe (CN)6.
After incubation at 50 ± 0 °C for 20 min, trichloroacetic acid
(10%) was added, and the mixture was centrifuged at 650×g
for 10 min. Finally, 50 µL of the upper layer was mixed with
distilled water and 0.1% of aqueous  FeCl3, and then absorb-
ance was measured at 700 nm.
2.2.3.4 β‑Carotene Bleaching Test A modification of the 
method described by Koleva et  al. [29] was employed. 
(1)% Inhibition = 100 ×
[(
A(blank) − A(sample)
)
∕A(blank)
]
.
β-carotene (2  mg) was dissolved in 20  mL chloroform, 
and to 4  mL of this solution, linoleic acid (40  mg) and 
Tween 40 (400 mg) were added. Chloroform was evapo-
rated under reduced pressure at 40 ± 0 °C and 100 mL of 
oxygenated ultra-pure water was added, then the emul-
sion was vigorously shaken. An aliquot (150  µL) of the 
β–carotene/linoleic acid emulsion was distributed in 
each of the wells of 96-well plate, and solutions of the 
test samples (10  µL) were added. Three replicates were 
prepared for each sample. The plates were incubated at 
50 ± 0 °C for 120 min. Absorbance was measured immedi-
ately (t = 0 min) and after incubation (t = 120 min) using a 
model EAR 400 plate reader (LabSystems Multiskan MS) 
at 470 nm. The β-carotene bleaching ability of the samples 
was determined using following formula:
where Ac (0) and Ac (120) are the absorbance values of the 
control at (t = 0 min) and (t = 120 min), respectively, and 
As (120) is the sample absorbance at 120 min. The results were 
expressed as  IC50 values (mg/mL).
2.3  Statistical Analysis
All data were expressed as mean ± standard deviation of 
triplicate measurements. The confidence limits were set at 
p < 0.05. Correlations were carried out using the correla-
tion and regression in the  Microsoft® EXCEL program. 
Data analysis procedure (ANOVA) was performed into 
evaluate results.
3  Results
3.1  Determination of pH
The skin is covered with a hydrolipidic film, which deter-
mines the skin pH. Thus, determination of a topical for-
mulation’s pH is an important factor for its efficiency. 
The blank bigel (BG) which is a preparation devoid of 
the active molecule is tested to insure its skin tolerance. 
 Cetavlon® has also been evaluated as a reference; it is 
a pharmaceutical formulation (cream) with a synthetic 
active compound (cetrimide) with antioxidant activities 
[30]. As shown in Table 2, the pH of freshly prepared con-
trol was 5.8 ± 0.2, whereas the pH of BG-M1 and BG-M2 
were 5.3 ± 0.1 and 5.4 ± 0.1, respectively, which is within 
the range of skin pH. The pH value of  cetavlon® was also 
suitable for skin (5.5 ± 0.2).
(2)
Inhibition (%) =
[(
As (120) − Ac (120)
)
∕
(
Ac (0) − Ac (120)
)]
∗ 100.
3.2  Rheological Study
The flow property of a formulation is one of its major char-
acteristics. Thus, measuring such feature is very essential. 
The viscosity values of bigels present a non-Newtonian 
shear-thinning flow behavior (pseudoplastic fluid), iden-
tified by a weakening in the viscosity with a reciprocal 
rise in the shear rate, as shown in Fig. 2c, which presents 
the viscosity as a function of shear rate. The shear thin-
ning property is a typical and suitable with the semisolid 
systems.
3.3  Physical Stability
In order to characterize the prepared bigels, various crite-
ria were used, namely the physical stability. In this study, 
centrifugation test was performed for all samples stored at 
25 ± 2 °C. Results are represented in Table 2. No phase sepa-
ration after centrifugation was seen in any of the samples.
3.4  Microscopic Observations
Prepared bigels (control) were characterized by the pres-
ence of micrographs and a porous structure, which promote 
their use in the field of drug system delivery (Fig. 2b). All 
samples present a tridimensional network constituted by an 
interconnected porosity, and the pores were regular in size 
for blank bigel and bigel with active molecules and BG-M2. 
All formulations have shown small uniform droplets regular 
in terms of size and number. Bigels have kept their micro-
structure even after incorporation of active M1 (Fig. 3a) and 
M2 (Fig. 3b).
3.5  Formulation Stability
Microbial quality of the developed formulation was observed 
at the end of experiments (one year after its preparation). 
There was no change in the color, aspect, and microbial 
growth of the formulation during the storage time (Table 2).
Table 2  Physicochemical indices of tested samples including blank 
bigel, bigels with M1 and M2, and  cetavlon®
a +: stable (no phase separation)
b +: stable (no microbial development)
Samples BG BG-M1 BG-M2 Cetavlon®
Physical  stabilitya + + + +
Formulation  stabilityb + + + +
pH 5.8 ± 0.2 5.3 ± 0.1 5.4 ± 0.1 5.5 ± 0.2
3.6  Sensory Analysis
Sensory evaluation was developed to collect sensory 
description of prepared formulations from consumers. 
Obtained data performed on a panel of 60 people are rep-
resented in Fig. 4. Several organoleptic properties were 
evaluated on the formulated bigels (BG-M1 and BG-M2): 
before (homogeneous appearance), during (ease of spread-
ing, penetration time), and after application (oily/fatty, fresh-
ness). The homogeneity of bigels was well perceived (7.4 
and 7.1/10 for BG-M1 and BG-M2, respectively) by the 
panel. During application, spreading was perceived as easy 
(7.6 and 6.6/10 for BG-M1 and BG-M2, respectively) with 
a satisfying penetration time (7.0 and 6.5/10 for BG-M1 and 
BG-M2, respectively). After application, the bigel seemed to 
 
Fig. 2  Characterization of 
blank bigel; a developed bigel 
(alginate and organogel), b 
microscopic observation 3D 
(50 ×); c effect of shear rate on 
the viscosity
Fig. 3  Microscopic observa-
tions of developed bigels; a 
BG-M1, b BG-M2. Reference 
bar corresponds to 50 µm
Fig. 4  Data of sensory analysis of bigels made on a panel of 60 people
be non-oily (6.4 and 7/10 for BG-M1 and BG-M2, respec-
tively) with a sensation of hydration perceived as favorable 
(7.6 and 8.1/10 for BG-M1 and BG-M2, respectively) and a 
feeling of freshness (7.5 and 8.1/10 for BG-M1 and BG-M2, 
respectively).
3.7  Antioxidant Assays
The radical-scavenging capacity of samples was evalu-
ated with the DPPH and ABTS assays as represented in 
Table 3. All samples have never been tested for their anti-
oxidant potential by previous investigators. Obtained data 
suggested a good scavenging capacity of free M1 and M2 
toward DPPH radicals, for M1 = (19 ± 0.0) × 10−3 mg/mL 
and for M2 = (35 ± 0.0) × 10−3 mg/mL. Even, after being 
incorporating in alginate bigels, they kept this potential. In 
fact, developed bigels have reported good radical-scavenging 
activity via DPPH assay with  IC50 equal to 3.0 ± 0.4 and 
1.1 ± 0.2 mg/mL for BG-M1 and BG-M2, respectively.
The capacity of samples to scavenge free radicals was 
also, determined by another method based on decoloriza-
tion of the solution of ABTS° + cation, at a specific absorb-
ance (734 nm) for a precise time of incubation. Free qui-
nones have showed a high antioxidant effect by scavenging 
ABTS radical with  IC50 equal to (1.5 ± 0.0) × 10−3 and 
(2.5 ± 0.0) × 10−3 mg/mL for M1 and M2, respectively. 
The potential of free molecules against ABTS radical 
had decreased, when incorporated into bigels with  IC50 
equivalent to 1.7 ± 0.1 and 4.9 ± 0.4 mg/mL for BG-M1 
and BG-M2, respectively. Similarly, concerning the reduc-
ing power, formulated bigels presented interesting capaci-
ties with  IC50 equivalent to 4.1 ± 0.1 and 4.9 ± 0.2 mg/mL 
for BG-M1 and BG-M2, respectively, but less important 
than those of free quinones, which showed  IC50 equal to 
(2.3 ± 0.3) × 10−3 and (1.1 ± 0.1) × 10−3 mg/mL for M1 and 
M2, respectively. As well, developed formulations revealed 
less important β-carotene bleaching inhibition  (IC50 equal 
to 2.9 ± 0.1 and 10.3 ± 0.5 mg/mL for BG-M1 and BG-M2, 
respectively) than pure molecules  (IC50 equal to 0.3 ± 0.0 
and 0.1 ± 0.0 mg/mL for M1 and M2, respectively).
4  Discussion
The pH of prepared bigels with or without active mole-
cules was found to be around 6 which is suitable for topical 
application as the skin pH of normal subjects has a range 
of 4.5 to 6.0 as defined by Jennifer et al. [31]. All tested 
preparations were found to enhance a safe application to 
the skin without irritation problems.
Biphasic formulation (organogel and hydrogel) affects 
the rheology of the bigel itself by its viscosity and chemi-
cal ingredients [32]. The rheological characteristics of 
bigels investigated in the current study are similar to those 
of semisolid systems gels used in cosmetic or pharmaceu-
tical applications [33–35]. This formulation guarantees 
a maximum area and simple utilization during a topical 
application. Those data are in line with Singh et al. [36] 
who found that bigels for topical delivery of metronidazole 
showed a non-Newtonian behavior.
Centrifugation was used as a helpful means to deter-
mine the physical stability of formulations [37]. Data 
showed no sign of separation phase, which reflect a 
proper homogenization speed during bigel development, 
and proved that formulated bigels were stable considering 
phase separation as a parameter of stability.
These formulations were also observed by microscope 
3D. They showed uniformly distributed droplets with a 
network of apolar phase of organogel. Hence, this observa-
tion confirmed the formation of oil in water type of bigel, 
as confirmed previously by the rheological study. The dis-
persion of microparticles may reflect the possibility that 
big droplets have broken into smaller ones when higher 
shear force was applied. The flow of microparticles may 
be resulting on the decrease of viscosity [36].
Formulation stability of prepared bigels revealed no 
microbial growth during the experimentation period. That 
verified the requirements of European Pharmacopoeia 
[23–25], and determined the antimicrobial property of 
BG-M1 and BG-M2, which could protect the bigels against 
microorganism contamination. As formulated bigels have 
Table 3  In vitro antioxidant 
activity of samples as  IC50 (mg/
mL) via scavenging abilities, 
reducing power, and β-carotene 
bleaching test
Data are expressed as mean ± standard deviation (n = 3); –: absence of activity
Samples/activities Scavenging activity Reducing power β-carotene 
bleaching 
activityABTS DPPH
BG-M1 1.7 ± 0.1 3.0 ± 0.4 4.1 ± 0.1 2.9 ± 0.1
BG-M2 4.9 ± 0.4 1.1 ± 0.2 4.9 ± 0.2 10.3 ± 0.5
BG – – – –
Cetavlon® – – 15.4 ± 1.1 –
Free M1 (1.5 ± 0.0) × 10−3 (19 ± 0.0) × 10−3 (2.3 ± 0.3) × 10−3 0.3 ± 0.0
Free M2 (2.5 ± 0.0) × 10−3 (35 ± 0.0) × 10−3 (1.1 ± 0.1) × 10−3 0.1 ± 0.0
not developed microbes and alginate had no antibacterial 
activity, it might be due to the presence of free quinones 
M1 and M2 within these formulations, which enable them 
to have antimicrobial properties.
Sensory analysis was evaluated in order to define the cus-
tomer preferences. Obtained results were relatively pleasant 
for the general aspect of the formulations. For tested prepa-
rations, the bigel was obtained by mixing the organogel and 
the hydrogel at 50/50 w/w. These proportions must not be 
modulated in order to preserve these organoleptic proper-
ties. Indeed, this proportion is the one that is responsible for 
touch perceived acceptable as well as the penetration time 
during and after application.
During this work, antioxidant potential of formulated 
bigels and free compounds were evaluated. We found that 
free quinones M1 and M2 have shown antioxidant activities 
through the DPPH assay; (19 ± 0.0) × 10−3 mg/mL for M1 and 
(35 ± 0.0) × 10−3 mg/mL for M2. Even, when introducing into 
formulated bigels, they have kept their scavenging capacities 
against DPPH radical with  IC50 equal to 3.0 and 1.1 mg/mL 
for BG-M1 and BG-M2, respectively. Also, the scavenging 
ability toward ABTS radical cation of free M1 and M2 had 
decreased for more than thousand times, after processing, as 
shown in Table 3, which represented also the reduction of 
their iron reducing power for almost the same values.
Moreover, the capacity of samples to inhibit the auto-oxi-
dation of polyunsaturated fatty acids was performed using 
the β-carotene bleaching assay. Free M1 showed an inhibi-
tion almost ten times higher than prepared BG-M1, likewise, 
free M2 had reported a β-carotene bleaching inhibition one 
hundred times more interesting than developed BG-M2. This 
might be due to interactions between pure molecules and 
the bigel matrix, thus covering the chromophore of M1/M2 
or causing changing of its position, shape or conformation, 
resulting in a decrease of the activity. Also, this phenomenon 
might be explained by the formation of a complex between 
pure molecules and fatty acids of organogel, which created 
a suitable environment making free M1 and M2 lazy when 
exerting their effect.
It is important to highlight that despite the antioxidant 
potential’s decrease of free molecules (against the ABTS 
and DPPH radicals, reducing power and β-carotene bleach-
ing inhibition), formulated bigels have preserved their 
antioxidant power which was more important than that of 
 cetavlon®. The absence of any antioxidant effect of blank 
bigel (BG) guarantees that the bigel’s antioxidant poten-
tial is specific to the molecules themselves. This could be 
explained by the fact that active compounds have found a 
suitable environment with matrix of bigel, so they were able 
to preserve their antioxidant power.
During this study, we succeeded to formulate bigels for 
topical application with a high quality and good stability 
protecting skin from oxidative stress damages mediated 
aging and UV radiations. Several studies have reported 
the antioxidant potential of plants preventing oxidative 
disorders [38] and reducing ROS production involved in 
skin damages [39, 40]. As our knowledge could be certain, 
this is the first work describing the antioxidant effect of 
M1 and M2 on the one hand, and their formulation within 
alginate bigel for topical application, on the other hand. 
Therefore, comparison with other works could be taken 
just with molecules of the same family. Our data is in 
accordance to what was reported by Soussi et al. [41], 
who have demonstrated the potent antioxidant effect of 
phenolic compounds of Juglans regia, and data found by 
Casagrande et al. [42], that quercetin, a flavonoid, which 
kept its antioxidant and showed protective effect against 
UVB-induced oxidative stress in hairless mice after pro-
cessing. Other investigators have developed alternative 
delivery systems for pure compounds, such as Moham-
mad et al. [43], who have formulated rutin in nanoemul-
sion system.
In this study, we formulated preparations in which 
water and oil content in formula contains more than 70% 
by weight of the bigel. Microscopic observations showed 
that all formulations (bigel control and bigel with active 
molecules) were semisolid preparations with distribution 
of polar phase and apolar one. Similarly for the BG, the 
BG-M1 and BG-M2: there was no change occurred in 
color up to the observation period of more than 12 months. 
This showed the stability of bigels at 25 ± 2 °C.
5  Conclusion
Performed examinations of formulated bigels with M1 and 
M2 proved a significant antioxidant potential and suitable 
chemical and formulation stability. The prepared bigels 
showed non-Newtonian behavior, which reflecting their 
Pseudoplastic tendency, resulting in the formation of a 
coherent film covering the skin surface. This property is 
valuable and critical for a better fortification of the skin 
surface. Bigels have also shown a good spreadability, 
no evidence of phase separation, good consistency, high 
stability parameters, and no microbial growth during the 
experiment period. Sensory analysis of the formulations 
showed that prepared bigels were pleasant by the panel of 
60 people. These developed bigels maintaining or improv-
ing the antioxidant potential of M1 and M2 could be used 
as the provision of a barrier to protect skin.
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